Payden Equity Income Adviser PYVAX
18.66 USD -0.61 (-3.17%)
At close·Nov 5, 2026, 8:03 PM EST
Day range unavailable
16.61 52-week range 19.36
- YTD
- +10.35%
- 1 year
- +6.45%
Altman Z-Score
101.23 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E 5.5×
P/S 0.0×
P/B 0.0×
P/FCF 0.0×
EV/EBITDA 0.0×
EV/Sales 0.0×
FCF Yield 0.0%
Gross Margin 100.0%
Operating Margin 23.8%
Net Margin 1213.7%
ROE 17.5%
ROIC 0.3%
ROA 17.3%
Revenue -12.3%
Operating Income -23.4%
EPS (diluted) 209.5%
Free Cash Flow 0.0%
Current Ratio 0.7×
Quick Ratio 0.7×
Debt / Equity 0.0×
Net Debt / EBITDA 0.0×
Interest Coverage 0.0×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2023-09-30